Thu 25 Jun 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis | Novartis | Ongoing | Fingolimod (Glienya) | 4 | FTY720D2404 | King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh) |
| Effect of heparin 20 u /kg/hr. continuous infusion on central venous catheter related thrombosis in children. | KAIMRC | Ongoing | HEPARIN | 4 | RC12/145 | King Abdulaziz Medical City NG (Riyadh) |
| Evaluation of Changes in Quality of Life and Socio-Professional Status in Subjects with Moderate to Severe Plaque Psoriasis Treated with Adalimumab in Routine Medical Practice - EQUIPE | AbbVie | Completed | Adalimumab | 4 | 10241 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Randomised Controlled Trial of Meropenem versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream | The University of Queensland, Australia | Ongoing | Meropenem / Piperacillin-Tazocin | 4 | MED0313 | King Fahad Specialist Hospital (Dammam) |
| Monitoring of Unfractionated Heparin Therapeutic Level by Using Activated Partial Thromboplastin Time Versus Anti factor Xa Levels | KAIMRC | Ongoing | Multiparin | 4 | RC15/022/R | King Abdulaziz Medical City NG (Riyadh) |
| XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study | Bayer | Ongoing | Xarelto | 4 | 16691 | Prince Sultan Cardiac Center (Qassim), Abdul Rahman Al-Mishari Hospital (Riyadh), King Fahad Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh), Dallah Hospital (Riyadh), Prince Sultan Cardiac Center (Riyadh) |
| Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on Pegylated Interferon for the Treatment of Chronic Hepatitis C | Roche | Ongoing | Pegasys | 4 | MV25599 | King Abdullah Medical City (Makkah), King Faisal Specialist Hospital and Research Center (Riyadh), Prince Sultan Military Medical City (Riyadh) |
| Impact on glycaemic control of the intensification of insulin therapy proposed by ADA/EASD guidelines with insulin glargine as pasal insulin plus a single daily dose of insulin glulisine at main meal : Basal plus strategy in real life | Sanofi | Ongoing | Lantus®/Apidra® | 4 | APIDR_L_05185 | King Abdulaziz University Hospital (Jeddah), Armed Forces Hospital (Taif) |
| A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM) | Novartis | Ongoing | Everolimus | 4 | CRAD001A2433 | Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam) |
| A Prospective Multicentre Randomised Controlled Trial of Early Goal Directed Sedation Compared with Standard Care in Mechanically Ventilated Patients in Intensive Care | Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) | Ongoing | Dexmedetomidine | 4 | RC 12-079 | King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.